II. Background
III. Indications: Low dose Aspirin 81 mg daily (more specific as of 2012)
- Framingham risk >10%, no vascular disease, and no Bleeding Diathesis
- Males over age 50 years or females over age 60 years and
- One additional Cardiovascular Risk Factor
- Tobacco Abuse
- Hypertension
- Dyslipidemia
- Albuminuria
- Family History of premature cardiovascular death
IV. Indications: Clopidogrel (Plavix) 75 mg daily
- Known cardiovascular disease
V. Adverse Effects
- See Aspirin
- Aspirin does not increase risk of Retinal Hemorrhage
Images: Related links to external sites (from Bing)
Related Studies
Concepts | Therapeutic or Preventive Procedure (T061) |
Italian | Terapia antipiastrinica |
Japanese | 抗血小板療法, コウケッショウバンリョウホウ |
Czech | Antiagregační léčba |
English | antiplatelet therapy, Antiplatelet therapy |
Hungarian | Thrombocyta-gátló kezelés |
Portuguese | Tratamento anti-plaquetas |
Spanish | Tratamiento antiplaquetario |
Dutch | antibloedplaatjestherapie |
French | Traitement antiplaquettaire |
German | Therapie mit Thrombozytenaggregationshemmer |